全部

1·This drug is an angiotensin converting enzyme inhibitor.

本品是一种血管紧张素转换酶抑制剂。

2·A diagnostic test kit for detecting the presence or quantity of an enzyme or enzyme inhibitor is provided.

提供一种用于检测酶或酶抑制剂的存在或数量的诊断试验试剂盒。

3·The diagnostic kit utilizes reactive complexes to facilitate the detection of the enzyme or enzyme inhibitor.

所述诊断试剂盒利用反应性复合物来方便酶或酶抑制剂的检测。

4·Angiotensin converting enzyme inhibitor may increase the sensitivity of tissue to intrinsic and extrinsic insulin.

血管紧张肽转换酶抑制药可增加组织对内源性和外源性胰岛素的敏感性。

5·Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor(ACEI) captopril on ischemic myocardium.

目的评价血管紧张素转换酶抑制剂（ACEI）卡托普利对缺血心肌的药理作用。

6·Kinetic analysis revealed that the inhibition on chymotrypsin by S-24 enzyme inhibitor is competitive with respect to the substrate.

动力学研究表明s - 24酶抑制剂抑制糜蛋白酶，对底物酪蛋白、血红蛋白的关系均为竟争性抑制。

7·CONCLUSION:DZ inhibited the 4 hydroxytative metabolic pathway of AP, suggesting DZ may be a potent and selective microsomal enzyme inhibitor.

结论：DZ选择性地抑制了AP在人体肝脏中的4羟基化代谢途径，提示DZ是一作用较强的、选择性的肝药酶抑制剂。

8·Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?

血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂联合用药治疗CKD是否比单药应用要好？

9·Objective To introduce the research and market development of enalapril as an angiotensin 1-converting enzyme inhibitor (ACEI) for treating hypertension.

目的介绍抗高血压药血管紧张素转化酶抑制剂（ACEI）依那普利的研发及市场情况。

10·The signal exhibited by the released reporters may then be used to indicate the presence or quantity of an enzyme or enzyme inhibitor within the test sample.

由释放的报道 分子所显示的信号可用来指示试验样品内酶或酶抑制剂的存在或数 量。